Foot drop is one of the earliest and most functionally disruptive signs of ALS when the disease affects the lower limbs. It results from weakness in the muscles that lift the front of the foot during walking, and it tends to appear well before the larger, more powerful muscles of the calf and thigh are noticeably affected. Because the ankle turns out to be a critical pivot point for normal walking, even mild weakness there can cascade into altered stride patterns, increased fatigue, and a rising risk of falls. Understanding how this distal weakness unfolds and what can be done about it matters for preserving mobility as long as possible.
Why ALS Preferentially Weakens the Front of the Ankle
In a healthy leg, dorsiflexion (pulling the toes upward) and plantar flexion (pushing them down, as in a calf raise) are roughly balanced in their contributions to walking. ALS disrupts that balance in a lopsided way. A study of people with ALS who had lower-limb involvement found that the proportion with decreased dorsiflexion strength was roughly twice that of those with decreased plantar flexion strength. When researchers compared the two sides directly in individual limbs, dorsiflexion was weaker than plantar flexion in about 61% of limbs, while the reverse was true in fewer than 2%.1Nature. Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis and its differential diagnosis value This “split” between dorsiflexors and plantar flexors is not random. The tibialis anterior, the primary muscle responsible for dorsiflexion, is innervated by motor neurons that appear to be especially vulnerable in ALS. The gastrocnemius and soleus muscles that power plantar flexion are relatively spared early on. The result is foot drop: the front of the foot hangs when the leg swings forward, forcing the person to compensate just to clear the ground.
This dorsiflexion-dominant weakness pattern distinguishes ALS from some other conditions that cause lower-limb problems. In lumbar spondylosis or peripheral neuropathies, the ratio of dorsiflexion to plantar flexion weakness follows a different signature. Researchers have used a “split index” comparing these two muscle groups as a diagnostic aid and found that it can help differentiate ALS from both normal controls and conditions like lumbar spondylosis with moderate accuracy.2Scientific Reports. Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis and its differential diagnosis value For clinicians evaluating someone with a new foot drop, this asymmetric weakness pattern is an early clue that ALS, rather than a pinched nerve or other localized problem, might be at work.
The Pseudopolyneuritic Presentation
Not every case of ALS-related foot drop looks like a textbook motor neuron disease at first. A subset of patients present with what clinicians call the “pseudopolyneuritic” form: distal weakness in the lower limbs that mimics a peripheral neuropathy. In a series of patients with lower-limb-onset ALS, a small group had foot drop combined with absent Achilles tendon reflexes and distal-predominant weakness, a combination that initially looked more like nerve damage than a degenerative motor neuron disease.3Neurosurgery Quarterly. Pseudopolyneuritic Form of Amyotrophic Lateral Sclerosis With Foot Drop: Anatomic and Electrophysiologic Study This presentation can delay diagnosis because the initial workup often chases peripheral nerve causes first. For someone experiencing progressive foot drop, especially if it began on one side and is creeping to involve more muscles, the possibility of ALS should be on the table even if the reflexes do not follow the “classic” upper motor neuron pattern.
How Foot Drop Reshapes Walking
Foot drop does not just make lifting the toes harder. It forces the entire leg and hip to compensate, setting off a chain of gait changes that grow more pronounced over time. When the ankle cannot dorsiflex properly during the swing phase of walking, a person may hike the hip, swing the leg outward, or exaggerate knee flexion just to keep the toe from catching the ground. These workarounds demand more effort from muscles that are themselves gradually weakening.
Research using a mouse model of ALS identified gait changes consistent with foot drop remarkably early in the disease course. Increases in hind paw print length during the stance phase appeared well before overt muscle wasting, suggesting that subtle biomechanical shifts at the ankle may be among the first measurable signs of motor neuron loss.4PubMed Central. Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis In humans, the picture is similar. A joint-level biomechanical analysis of people with motor neuron disease concluded that the ankle is an early and critical point of dysfunction. Distal weakness at the ankle drives compensatory strategies at the knee and hip, and those compensations increase walking inefficiency and fatigue.5PubMed. Lower-limb biomechanics in motor neuron disease: a joint-level perspective of gait disruption
What this means in daily life is that walking becomes more tiring long before it becomes impossible. You burn more energy per step because you are routing effort through larger, less efficient muscle groups. Fatigue from walking then compounds the weakness itself, creating a cycle where reduced activity leads to further deconditioning on top of the underlying disease.
Falls and Their Consequences
Falls are a major concern for anyone living with ALS, and foot drop is a significant contributor. Tripping over an unlifted toe on a rug edge, a threshold, or uneven ground is one of the most common fall scenarios. A study looking at falls in ALS found a significant correlation between fall incidence and composite lower-extremity strength scores.6PubMed Central. Correlation of falls in patients with Amyotrophic Lateral Sclerosis with objective measures of balance, strength, and spasticity As the muscles weaken, the margin for error while walking shrinks. A surface that a healthy ankle could adjust to mid-stride becomes a hazard when dorsiflexion is compromised.
Falls in ALS carry outsize consequences compared to falls in the general population. The same disease that weakens the ankle also weakens the arms and trunk, making it harder to catch yourself. Recovery from injuries like fractures is complicated by progressive muscle loss. Fear of falling can also lead people to restrict their own mobility earlier than necessary, accelerating the shift to wheelchair dependence. Addressing foot drop early is partly about walking better, but it is also about buying time before falls force a more drastic change in how someone gets around.
Progression Patterns in Lower-Limb-Onset ALS
When ALS begins in a lower limb, which accounts for roughly a quarter of all cases, the trajectory of spread carries important prognostic information. A study tracking lower-limb-onset patients found that the median time for weakness to spread beyond the leg where it started was about 12 months. Spread to the opposite leg took an average of 21 months, and spread within the same side of the body averaged 16 months.7PubMed Central. Pattern of spread and prognosis in lower limb-onset ALS Crucially, the speed of that initial spread was one of the strongest predictors of overall survival. Patients whose weakness remained confined to one leg for a longer period before spreading lived longer; overall survival from symptom onset roughly approximated two years plus however many months it took for the disease to spread beyond the initial limb.
A separate retrospective study found that the median time from diagnosis to loss of ambulation across all ALS patients was about 16.5 months. Shorter time from symptom onset to diagnosis was associated with faster loss of walking ability, likely reflecting more aggressive disease rather than any harm from diagnosis itself.8Wiley Online Library (Health Science Reports). Factors Influencing the Loss of Ambulation in Patients With Amyotrophic Lateral Sclerosis: A Retrospective Cohort Study These timelines are averages with wide variation. Some people walk for years; others lose ambulation within months. But the general pattern is clear: foot drop is typically the opening chapter of a story that unfolds over a year or two before walking becomes impractical.
Tracking Decline at the Ankle
Measuring what is happening at the ankle over time matters for clinical trials and for individual patient management. Two main approaches capture the trajectory of distal motor loss.
Electrophysiology offers a direct window into motor axon health. Compound muscle action potential amplitude, recorded from the tibialis anterior muscle (the one that lifts the foot), correlates well with voluntary strength and shows a roughly linear decline over time in many patients. Researchers have proposed it as a translational measure of disease progression because the same electrical recording can be done in both animal models and humans, making it easier to evaluate whether a therapy that works in mice actually translates to people.9PubMed. Maximizing the translational potential of neurophysiology in amyotrophic lateral sclerosis: a study on compound muscle action potentials An older study confirmed this relationship, showing that compound muscle action potential amplitude from the tibialis anterior correlated strongly with maximum voluntary contraction and with time, suggesting it could substitute for strength testing in clinical trials when direct strength measurement is not feasible.10PubMed. Use of electrophysiologic tests to measure disease progression in ALS therapeutic trials
Ultrasound is emerging as a complementary tool. A pilot study using imaging of the tibialis anterior found that muscle thickness was lower in ALS patients both at rest and during contraction, and the difference in thickening capacity correlated with clinical strength scores and functional ratings.11ScienceDirect (NeurologÃa (English Edition)). Dynamic analysis of muscles and the internal structure of the peripheral nerve as biomarkers of amyotrophic lateral sclerosis: A pilot study with ultrasound imaging Ultrasound is painless, portable, and quick, making it a practical option for repeated assessments in a clinic setting. It can also reveal changes in nerve structure that accompany the muscle thinning, potentially adding another layer of information about how fast the disease is advancing in a specific limb.
Wearable Sensors and Real-World Gait Monitoring
Clinic visits capture a snapshot of how someone walks on a given day, but they miss the daily fluctuations and gradual changes that happen between appointments. Wearable sensors worn on the foot or at the waist are changing that. In a study of ambulatory ALS patients, foot-worn inertial sensors tracked home walking speed over 24 weeks and found a significant decline averaging about 0.02 meters per second per month in more than half the participants. People who eventually needed an assistive device showed steeper declines than those who did not.12Digital Biomarkers. Spatial-Temporal Analysis of Gait in Amyotrophic Lateral Sclerosis Using Foot-Worn Inertial Sensors: An Observational Study
Larger ongoing studies are evaluating sensor-derived measures like stride count per hour and peak walking speed as clinical trial endpoints. Preliminary results from 47 enrolled ALS patients suggest that these digital measures correlate with established clinical scales and may detect decline at three-month intervals with greater sensitivity than traditional in-clinic tests.13MDA Conference. Wearable Sensor-Derived Digital Outcomes for Quantifying Gait in ALS For researchers, this sensitivity is important because clinical trials in ALS are often short and sample sizes small; an endpoint that picks up changes faster could make it possible to detect a treatment effect that would otherwise be missed. For patients, the technology could eventually feed data back to their care team between visits, flagging an acceleration in gait decline that warrants a call or an earlier appointment.
A separate evaluation confirmed the feasibility of using sensors during guided walks in an ALS clinic, with both waist- and foot-mounted devices independently estimating gait parameters.14PubMed. Inertial sensing of step kinematics in ambulatory patients with ALS and related motor neuron diseases While these tools are not yet standard of care, they are being integrated into research protocols at a growing number of ALS centers.
Managing Foot Drop to Preserve Mobility
There is no treatment that reverses ALS-related foot drop, but several interventions can slow the practical consequences and keep someone walking safely for longer. The most common first step is an ankle-foot orthosis, a lightweight brace worn inside the shoe that holds the foot in a neutral or slightly dorsiflexed position. A well-fitted orthosis prevents the toe from dragging and reduces the need for the exhausting compensatory hip-hiking and circumduction patterns described earlier. The trade-off is that it adds stiffness at the ankle, which can feel awkward and may reduce the push-off power that the relatively preserved plantar flexors still provide. Getting the right balance requires working with an orthotist who understands how ALS differs from a static nerve injury.
Functional electrical stimulation (FES) is an alternative for some patients. A small device stimulates the peroneal nerve during the swing phase of gait, electrically triggering the dorsiflexion that the motor neurons can no longer produce reliably. A study of FES for foot drop (in a mixed population including both progressive and non-progressive neurological conditions) found that walking speed increased even with the stimulator turned off, suggesting some carry-over training effect. The improvements were larger in the non-progressive group, but even participants with progressive disease showed modest gains in walking speed.15PubMed Central. Does functional electrical stimulation for foot drop strengthen corticospinal connections? In ALS specifically, FES is most useful in earlier stages when enough motor neurons remain to respond to stimulation. As the disease advances and motor axons are lost, the muscles become less responsive to external electrical input.
Stretching and range-of-motion exercises play a supporting role. While the evidence for sustained improvement in range of motion from stretching alone in neuromuscular diseases is limited, there are generally accepted principles around splinting, bracing, and stretching to minimize the impact of contractures.16PubMed Central. Prevention and management of limb contractures in neuromuscular diseases Contractures at the ankle can develop when the stronger plantar flexors gradually shorten against the weakened dorsiflexors, and once the ankle is fixed in a downward position, even bracing becomes difficult. Regular stretching and nighttime splinting aim to keep the joint supple enough that orthotic devices remain an option.
Home Modifications and Practical Strategies
Beyond devices worn on the body, environmental changes can substantially reduce the daily impact of foot drop. Removing loose rugs, securing electrical cords, installing threshold ramps over door sills, and adding grab bars in bathrooms address the most common tripping hazards. Good lighting in hallways and stairwells matters more than you might expect, because visual cues partially compensate for the impaired proprioceptive feedback from a weakened ankle.
Footwear choices make a difference too. Shoes with a firm heel counter and a low-profile sole reduce the tendency of the foot to catch on surfaces. Lace-up shoes or those with adjustable straps accommodate an orthosis while keeping the foot snug. Slip-on shoes, while convenient when hand function is still good, tend to fly off mid-stride when dorsiflexion is weak, which is as dangerous as it sounds.
For stairs, the general recommendation is to lead with the stronger leg when going up and the weaker leg when going down, using a railing on the side of the weaker leg. When foot drop progresses to the point where stairs are no longer safe, a stair lift or single-floor living arrangement becomes the practical step. Planning these transitions before a crisis, rather than after a fall, is one of the more impactful things a care team and family can do.
When Foot Drop Is Not ALS
It is worth noting that the vast majority of foot drop cases have nothing to do with ALS. Peroneal nerve compression at the knee, lumbar disc herniation compressing the L5 nerve root, and peripheral neuropathies from diabetes or other causes are far more common culprits. What distinguishes ALS-related foot drop is the pattern of progression: it does not stay put. A compressed peroneal nerve causes foot drop that stabilizes or improves once the pressure is relieved. A disc herniation typically produces foot drop with back pain and sensory loss in a specific nerve distribution. ALS-related foot drop worsens over weeks to months, spreads to involve other muscle groups, and eventually shows up on the opposite side. Upper motor neuron signs like brisk reflexes or spasticity in other limbs, when present alongside a lower motor neuron pattern at the ankle, strengthen the suspicion considerably.
The split between dorsiflexion and plantar flexion weakness discussed earlier can serve as one additional piece of the diagnostic puzzle. In lumbar spondylosis affecting the L5 root, both dorsiflexors and plantar flexors tend to be affected more evenly, whereas ALS disproportionately hits dorsiflexion first. No single test is definitive, and the diagnosis of ALS remains clinical, supported by electrophysiology. But the pattern of distal weakness at the ankle, its relentless progression, and its eventual spread to contiguous body regions form a recognizable trajectory that experienced clinicians learn to identify early.
The Ankle as a Canary in the Coal Mine
Researchers increasingly view the ankle joint as a bellwether for ALS progression in lower-limb-onset disease. Changes in tibialis anterior function, whether measured by strength testing, electrical recordings, ultrasound, or wearable gait sensors, tend to appear before changes in more proximal muscles and before traditional clinical scales register meaningful decline. This makes the ankle a natural target for outcome measures in clinical trials. If a drug slows the loss of motor neurons supplying the tibialis anterior, that effect should show up in dorsiflexion strength, in electrical recordings from the muscle, and in real-world gait speed captured by a sensor, potentially months before the broader functional scales move. The challenge is that no single ankle-level measure has been universally adopted as a primary endpoint in ALS trials yet. The field is still working out which combination of measures gives the clearest, most reliable signal of whether a treatment is actually doing something. But the convergence of evidence from animal models, human biomechanics, electrophysiology, and digital health tools all points to the same conclusion: what happens at the ankle early in ALS matters enormously for what happens to the whole person later.